Adlon Therapeutics LP
✓ Verified ManufacturerAbout
Adlon Therapeutics LP is a specialty pharmaceutical company based in Stamford, Connecticut, dedicated to developing innovative treatment solutions for patients suffering from Attention Deficit/Hyperactivity Disorder (ADHD). As a subsidiary of Purdue Pharma LP, the company leverages extensive pharmaceutical expertise to advance therapeutic options in the central nervous system disorder space. Founded in 2019, Adlon Therapeutics focuses specifically on small molecule development and ADHD treatment protocols, positioning itself as a targeted player in the neurological therapeutics market. The company operates with a clear mission to serve the ADHD community through comprehensive approaches that include developing cutting-edge medicines, promoting responsible prescription stimulant utilization, conducting meaningful research, and supporting evidence-based policies for appropriate ADHD diagnosis and treatment. Located at 201 Tresser Boulevard in Stamford, Adlon Therapeutics combines pharmaceutical manufacturing capabilities with specialized knowledge in attention deficit disorders. The company maintains a dedicated team of medical science liaisons and specialty sales representatives who work directly with healthcare providers to ensure optimal patient outcomes. Through its focused approach to ADHD therapeutics, Adlon Therapeutics continues to contribute to advancing treatment standards while maintaining commitment to patient safety and therapeutic efficacy in the specialized pharmaceutical manufacturing sector.